Overview
At the last IASLC World Conference on Lung Cancer (WCLC 2018) in Toronto, we learned that the ten year follow-up of the randomized, Dutch/ Belgian low-dose CT screening trial, NELSON, reported significant mortality reduction benefit, confirming the earlier report of the National Lung Screening Trial.
Since then, additional low-dose screening trials from Milan and Japan reported significantly positive mortality outcomes. From the discussions in Toronto, it is clear that a number of other countries are considering implementing lung cancer screening, but there are a number of issues regarding screening implementation that are of concern in various national settings. As a result, the IASLC decided to present examples of screening implementation to enhance understanding of how aspects of management for low-dose CT screening can be best approached.
In this webinar, Professor Witold Ryzman, MD, will share the experience on developing and implementing a pilot program to demonstrate how national screening for lung cancer in Poland can be implemented. Lung cancer screening in Poland is about to begin as a national demonstration project in 2019. The history of four pilot Polish projects that began in 2008 as well as the efforts of building a comprehensive screening centre in Gdansk as the way to build a final national program will be presented.
For any inquiries, please contact meetings@iaslc.org.